- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 213/32 - Sulfur atoms
Patent holdings for IPC class C07D 213/32
Total number of patents in this class: 75
10-year publication summary
|
4
|
6
|
8
|
7
|
6
|
5
|
1
|
4
|
0
|
1
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 5080 |
8 |
| Sumitomo Chemical Company, Limited | 8808 |
4 |
| Dow AgroSciences LLC | 1267 |
4 |
| Allergan, Inc. | 2600 |
3 |
| Institute of Materia Medica, Chinese Academy of Medical Sciences | 165 |
3 |
| T. Hasegawa Co., Ltd. | 80 |
3 |
| Dow Silicones Corporation | 1664 |
3 |
| BASF SE | 19740 |
2 |
| Mitsubishi Chemical Corporation | 4313 |
2 |
| Canbas Co., Ltd. | 21 |
2 |
| General Incorporated Association Pharma Valley Project Supporting Organization | 22 |
2 |
| Georgetown University | 591 |
2 |
| Santen Pharmaceutical Co., Ltd. | 649 |
2 |
| Schering Aktiengesellschaft | 40 |
2 |
| Zoetis Services LLC | 1537 |
2 |
| Horizon Orphan LLC. | 35 |
2 |
| Novo Nordisk A/S | 2324 |
2 |
| The Procter & Gamble Company | 22178 |
1 |
| Syngenta Participations AG | 4970 |
1 |
| Massachusetts Institute of Technology | 9795 |
1 |
| Other owners | 24 |